UZ Leuven, Neurologie Herestraat 49
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Coudoin, Sylvie
FTD-GRN, NCT04408625 / 2019-003159-12: Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations

Recruiting
1/2
30
Europe, US, RoW
LY3884963, Methylprednisolone, Optional Sirolimus, Optional Prednisone
Prevail Therapeutics, Eli Lilly and Company
Frontotemporal Dementia
08/29
08/29
Schildermans, Carine
FTD-GRN, NCT04408625 / 2019-003159-12: Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations

Recruiting
1/2
30
Europe, US, RoW
LY3884963, Methylprednisolone, Optional Sirolimus, Optional Prednisone
Prevail Therapeutics, Eli Lilly and Company
Frontotemporal Dementia
08/29
08/29
Pelat, Julie
FTD-GRN, NCT04408625 / 2019-003159-12: Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations

Recruiting
1/2
30
Europe, US, RoW
LY3884963, Methylprednisolone, Optional Sirolimus, Optional Prednisone
Prevail Therapeutics, Eli Lilly and Company
Frontotemporal Dementia
08/29
08/29
Capdevila, Beatriz Bosch
FTD-GRN, NCT04408625 / 2019-003159-12: Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations

Recruiting
1/2
30
Europe, US, RoW
LY3884963, Methylprednisolone, Optional Sirolimus, Optional Prednisone
Prevail Therapeutics, Eli Lilly and Company
Frontotemporal Dementia
08/29
08/29
DIAN, NCT00869817: Dominantly Inherited Alzheimer Network

Recruiting
N/A
700
Europe, Canada, Japan, US, RoW
Washington University School of Medicine, National Institute on Aging (NIA)
Alzheimer's Disease
07/25
07/25

Download Options